Company Registration No. 14574842 (England and Wales)
Nova Biochem Ltd
Unaudited accounts
for the year ended 31 December 2024
Nova Biochem Ltd
Unaudited accounts
Contents
Nova Biochem Ltd
Company Information
for the year ended 31 December 2024
Director
Dr Alexander Novitskiy
Company Number
14574842 (England and Wales)
Registered Office
Flat 33 Anchorage Point
42 Cuba Street
London
E14 8NE
England
Accountants
Lanamak Finance Ltd
128 City Road
London
EC1V 2NX
Nova Biochem Ltd
Statement of financial position
as at 31 December 2024
Cash at bank and in hand
90,871
271,514
Creditors: amounts falling due within one year
(2,998)
(8,171)
Net current assets
145,432
289,702
Net assets
151,062
290,692
Called up share capital
1
1
Share premium
449,999
449,999
Profit and loss account
(298,938)
(159,308)
Shareholders' funds
151,062
290,692
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 18 January 2025 and were signed on its behalf by
Dr Alexander Novitskiy
Director
Company Registration No. 14574842
Nova Biochem Ltd
Notes to the Accounts
for the year ended 31 December 2024
Nova Biochem Ltd is a private company, limited by shares, registered in England and Wales, registration number 14574842. The registered office is Flat 33 Anchorage Point, 42 Cuba Street, London, E14 8NE, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% on cost
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Expenditure on research and development is written off in the year in which it is incurred.
4
Tangible fixed assets
Computer equipment
Nova Biochem Ltd
Notes to the Accounts
for the year ended 31 December 2024
Amounts falling due within one year
6
Creditors: amounts falling due within one year
2024
2023
Taxes and social security
2,165
7,338
7
Average number of employees
During the year the average number of employees was 2 (2023: 1).